Clinical Trial

Efficacy of AI-Assisted Colonoscopy for Screening Colorectal Neoplasia (AI-COLOSCREEN)

Study acronym: AI-COLOSCREEN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multi-center, randomized controlled trial designed to evaluate whether an artificial intelligence (AI) system can assist endoscopists to improve the detection rate of colorectal adenomas and cancers during colonoscopy compared to standard colonoscopy. Early screening and diagnosis are key to reducing the burden of colorectal cancer, but current colonoscopy has limitations, including the risk of missed lesions. This trial aims to determine if AI can enhance screening quality and diagnostic accuracy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-14.
Trial Details
NCT Number NCT07307547
Lead Sponsor Zhejiang University
Conditions Colorectal Neoplasms, Colonic Polyp, Adenoma, Colorectal Cancer
Enrollment 3,342 participants
Start Date 2026-04
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-10